Documents & Downloads

Nelipepimut-S

HER2 Targeting Vaccine

Nelipepimut-S is a peptide vaccine that specifically targets the HER2 protein, which is overexpressed in certain breast cancers. This vaccine activates the immune system, promoting a targeted response against HER2-positive tumors. Nelipepimut-S is utilized in research focused on developing immunotherapies for breast cancer treatment and understanding the mechanisms of immune modulation in tumor environments.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	160212-35-1
Applications	HER2 Targeting Vaccine
Formula	C₅₀H₇₈N₁₀O₁₁
Molecular Weight	995.21
SMILES	[C@H](CC1=CC=CC=C1)(C(N[C@@H](CC(C)C)C(O)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CC2=CC=CC=C2)NC([C@@H](NC([C@H](CCCCN)N)=O)[C@H](CC)C)=O)=O)=O)CO)=O)CC(C)C)=O)C)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.